118 related articles for article (PubMed ID: 11374044)
1. Quantification of alpha 1-fetoprotein mRNA in peripheral blood and bone marrow: a tool for perioperative evaluation of patients with hepatocellular carcinoma.
Aselmann H; Wolfes H; Rohde F; Frerker M; Deiwick A; Jäger MD; Klempnauer J; Schlitt HJ
Langenbecks Arch Surg; 2001 Mar; 386(2):118-23. PubMed ID: 11374044
[TBL] [Abstract][Full Text] [Related]
2. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Morimoto O; Nagano H; Miyamoto A; Fujiwara Y; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Surg Today; 2005; 35(12):1033-41. PubMed ID: 16341483
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
[TBL] [Abstract][Full Text] [Related]
4. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
5. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
6. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
[TBL] [Abstract][Full Text] [Related]
7. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
8. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Matsumura M; Niwa Y; Kato N; Komatsu Y; Shiina S; Kawabe T; Kawase T; Toyoshima H; Ihori M; Shiratori Y
Hepatology; 1994 Dec; 20(6):1418-25. PubMed ID: 7527002
[TBL] [Abstract][Full Text] [Related]
9. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
[TBL] [Abstract][Full Text] [Related]
10. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Kienle P; Weitz J; Klaes R; Koch M; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
Arch Surg; 2000 Feb; 135(2):213-8. PubMed ID: 10668884
[TBL] [Abstract][Full Text] [Related]
11. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
[TBL] [Abstract][Full Text] [Related]
12. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
Wong IH; Yeo W; Leung T; Lau WY; Johnson PJ
Cancer Lett; 2001 Jun; 167(2):183-91. PubMed ID: 11369140
[TBL] [Abstract][Full Text] [Related]
14. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Witzigmann H; Geissler F; Benedix F; Thiery J; Uhlmann D; Tannapfel A; Wittekind C; Hauss J
Surgery; 2002 Jan; 131(1):34-43. PubMed ID: 11812961
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
17. Circulating Hepatocellular Cells are a Bad Prognostic Factor for HCC Patients.
Liu Y; Wang YR; Wang L; Xun LJ; Ding GH; Yao L
Hepatogastroenterology; 2015 Jun; 62(140):802-6. PubMed ID: 26902005
[TBL] [Abstract][Full Text] [Related]
18. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
[TBL] [Abstract][Full Text] [Related]
19. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
Wong IH; Leung T; Ho S; Lau WY; Chan M; Johnson PJ
Br J Cancer; 1997; 76(5):628-33. PubMed ID: 9303362
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]